cellestia biotech closed a funding round (amount undisclosed) in Aug 2021. The company is based in Lausanne, Switzerland. Investors in the round: SNGLR Capital. Data as of 21 Sept 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
